Apixaban is expected to provide stiff competition to warfarin, a popular blood thinner used in Europe. Warfarin is known to cause some serious side effects in patients. Apixaban, as compared with aspirin, reduced the risk of stroke or systemic embolism in patients experiencing atrial fibrillation ...
(AUC) anti-Xa effect over time in elderly vs young or men vs women within ±15%, mPT and INR within 15%–20% (the same holds in different races); body-weight effects on anti-Xa in agreement with the effect on total exposure (the same holds for the treated condition [THA/TKA, VTE...
(AUC) anti-Xa effect over time in elderly vs young or men vs women within ±15%, mPT and INR within 15%–20% (the same holds in different races); body-weight effects on anti-Xa in agreement with the effect on total exposure (the same holds for the treated condition [THA/TKA, VTE...